Clinical trial
Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal…
NCT00003225 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003225 |
|---|---|
| Title | Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer |
| Official title | Phase I/II Trial to Evaluate Ethyol as a Protective Agent for Irinotecan (CPT-11) Toxicities in Patients With Advanced Colorectal Cancer |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | ALZA Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | amifostine trihydrate, irinotecan hydrochloride |
| Enrollment | 23 |
| Start date | Jul 1, 1997 |
| Primary completion | Mar 1, 2000 |
| Completion | Jun 1, 2001 |
| First posted | Jul 21, 2004 |
| Last update posted | Aug 3, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: